Source: Basic & Clinical Pharmacology & Toxicology. Unidades: FMRP, FCFRP
Subjects: FARMACOLOGIA, VENENOS DE ORIGEM ANIMAL, BIOTECNOLOGIA
ABNT
DIOGO, Luciana C. et al. Inhibition of snake venoms and phospholipases 'A IND.2' by extracts from native and genetically modified eclipta alba: isolation of active coumestans. Basic & Clinical Pharmacology & Toxicology, v. 104, n. 4, p. 293-299, 2009Tradução . . Acesso em: 28 maio 2024.APA
Diogo, L. C., Fernandes, R. S., Marcussi, S., Menaldo, D. L., Roberto, P. G., Matrangulo, P. V. F., et al. (2009). Inhibition of snake venoms and phospholipases 'A IND.2' by extracts from native and genetically modified eclipta alba: isolation of active coumestans. Basic & Clinical Pharmacology & Toxicology, 104( 4), 293-299.NLM
Diogo LC, Fernandes RS, Marcussi S, Menaldo DL, Roberto PG, Matrangulo PVF, Pereira PS, França SC, Giuliatti S, Soares AM, Lourenço MV. Inhibition of snake venoms and phospholipases 'A IND.2' by extracts from native and genetically modified eclipta alba: isolation of active coumestans. Basic & Clinical Pharmacology & Toxicology. 2009 ; 104( 4): 293-299.[citado 2024 maio 28 ]Vancouver
Diogo LC, Fernandes RS, Marcussi S, Menaldo DL, Roberto PG, Matrangulo PVF, Pereira PS, França SC, Giuliatti S, Soares AM, Lourenço MV. Inhibition of snake venoms and phospholipases 'A IND.2' by extracts from native and genetically modified eclipta alba: isolation of active coumestans. Basic & Clinical Pharmacology & Toxicology. 2009 ; 104( 4): 293-299.[citado 2024 maio 28 ]